Boston Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-436
| Closed | -$227K | – | 767 |
|
|
2024
Q4 | $227K | Sell |
436
-33
| -7% | -$17.2K | ﹤0.01% | 700 |
|
|
2024
Q3 | $290K | Sell |
469
-3
| -0.6% | -$1.86K | ﹤0.01% | 695 |
|
|
2024
Q2 | $261K | Sell |
472
-334
| -41% | -$185K | ﹤0.01% | 689 |
|
|
2024
Q1 | $468K | Sell |
806
-70
| -8% | -$40.7K | ﹤0.01% | 703 |
|
|
2023
Q4 | $465K | Sell |
876
-948
| -52% | -$503K | ﹤0.01% | 618 |
|
|
2023
Q3 | $923K | Hold |
1,824
| – | – | ﹤0.01% | 557 |
|
|
2023
Q2 | $952K | Sell |
1,824
-853
| -32% | -$445K | ﹤0.01% | 548 |
|
|
2023
Q1 | $1.54M | Sell |
2,677
-6,353
| -70% | -$3.66M | ﹤0.01% | 489 |
|
|
2022
Q4 | $4.97M | Sell |
9,030
-2,447
| -21% | -$1.35M | 0.01% | 378 |
|
|
2022
Q3 | $5.82M | Sell |
11,477
-4,254
| -27% | -$2.16M | 0.01% | 382 |
|
|
2022
Q2 | $8.55M | Buy |
15,731
+2,653
| +20% | +$1.44M | 0.01% | 365 |
|
|
2022
Q1 | $7.73M | Buy |
13,078
+2,669
| +26% | +$1.58M | 0.01% | 377 |
|
|
2021
Q4 | $6.95M | Sell |
10,409
-2,500
| -19% | -$1.67M | 0.01% | 375 |
|
|
2021
Q3 | $7.38M | Sell |
12,909
-5,782
| -31% | -$3.3M | 0.01% | 374 |
|
|
2021
Q2 | $9.43M | Buy |
+18,691
| New | +$9.43M | 0.01% | 366 |
|
|
2014
Q1 | – | Sell |
-56,120
| Closed | -$6.25M | – | 746 |
|
|
2013
Q4 | $6.25M | Hold |
56,120
| – | – | 0.01% | 469 |
|
|
2013
Q3 | $5.17M | Hold |
56,120
| – | – | 0.01% | 485 |
|
|
2013
Q2 | $4.75M | Buy |
+56,120
| New | +$4.75M | 0.01% | 484 |
|